Umbrella Branding Is ‘Particular Concern’ As FDA Requests Research Proposals
This article was originally published in The Tan Sheet
FDA seeks research proposals to evaluate consumers’ understanding of OTC drugs bearing umbrella brand names. The agency says the data also will benefit regulatory action and future guidance development as well as provide knowledge to scientists studying risk communication of drugs.
Register for our free email digests: